Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea

Young June Choe, Ok Pil Han, Heeyeon Cho, Geun Ryang Bae, Byung-Chul Chun, Jong Hyun Kim, Kyung Hyo Kim, Hoan Jong Lee, Eun Hwa Choi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: This study was performed to determine the priority of vaccine introduction for five vaccine-preventable diseases (VPDs) caused by Haemophilus influenzae type b (Hib), pneumococcus (Spn), hepatitis A virus (HepA), rotavirus (RV), and human papillomavirus (HPV) to the future Korean National Immunization Program (NIP) and to suggest framework programs to assist decision makers on implementation of the NIP. Methods: Following analysis of the disease burden and economics of the five VPDs by the core team and Korean Advisory Committee on Immunization Practices sub-committee members, a Delphi survey was administered to 94 Korean experts using structured questionnaires that provided the reference data. The two evaluation frameworks for NIP prioritization were (1) a disease-related framework and (2) a vaccine-related framework. After analyzing the responses, a meeting of experts was held to build a consensus for determining how to prioritize NIP implementation. Results: The average scores for relative importance were 63.29 for the disease-related framework and 36.71 for the vaccine-related framework. Within the disease-related framework, the mortality and case fatality rate was the highest scored factor (8.97), whereas within the vaccine-related framework, efficacy of the vaccine was considered the most important factor (9.56). On average, Spn, Hib, and HepA had the highest priority scores. Conclusion: The Korean experts suggested that the main factors influencing the decision to adopt new vaccines in the Korean NIP should be disease mortality, case fatality, and the efficacy and effectiveness of the vaccine. Among the five selected VPDs, Spn, Hib, and HepA were considered to be of higher priority than RV and HPV.

Original languageEnglish
Pages (from-to)6049-6053
Number of pages5
JournalVaccine
Volume32
Issue number46
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Immunization Programs
Republic of Korea
prioritization
South Korea
immunization
Vaccines
vaccines
Hepatitis A virus
Haemophilus influenzae type b
Haemophilus influenzae
Papillomaviridae
Rotavirus
Influenza A virus
committees
Mortality
Human hepatitis A virus
Committee Membership
burden of disease
Cost of Illness
Advisory Committees

Keywords

  • Delphi survey
  • National Immunization Program
  • Priority

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea. / Choe, Young June; Han, Ok Pil; Cho, Heeyeon; Bae, Geun Ryang; Chun, Byung-Chul; Kim, Jong Hyun; Kim, Kyung Hyo; Lee, Hoan Jong; Choi, Eun Hwa.

In: Vaccine, Vol. 32, No. 46, 01.01.2014, p. 6049-6053.

Research output: Contribution to journalArticle

Choe, YJ, Han, OP, Cho, H, Bae, GR, Chun, B-C, Kim, JH, Kim, KH, Lee, HJ & Choi, EH 2014, 'Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea', Vaccine, vol. 32, no. 46, pp. 6049-6053. https://doi.org/10.1016/j.vaccine.2014.09.009
Choe, Young June ; Han, Ok Pil ; Cho, Heeyeon ; Bae, Geun Ryang ; Chun, Byung-Chul ; Kim, Jong Hyun ; Kim, Kyung Hyo ; Lee, Hoan Jong ; Choi, Eun Hwa. / Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea. In: Vaccine. 2014 ; Vol. 32, No. 46. pp. 6049-6053.
@article{62b7d2d6384a47b8b97aedd596ec45a0,
title = "Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea",
abstract = "Background: This study was performed to determine the priority of vaccine introduction for five vaccine-preventable diseases (VPDs) caused by Haemophilus influenzae type b (Hib), pneumococcus (Spn), hepatitis A virus (HepA), rotavirus (RV), and human papillomavirus (HPV) to the future Korean National Immunization Program (NIP) and to suggest framework programs to assist decision makers on implementation of the NIP. Methods: Following analysis of the disease burden and economics of the five VPDs by the core team and Korean Advisory Committee on Immunization Practices sub-committee members, a Delphi survey was administered to 94 Korean experts using structured questionnaires that provided the reference data. The two evaluation frameworks for NIP prioritization were (1) a disease-related framework and (2) a vaccine-related framework. After analyzing the responses, a meeting of experts was held to build a consensus for determining how to prioritize NIP implementation. Results: The average scores for relative importance were 63.29 for the disease-related framework and 36.71 for the vaccine-related framework. Within the disease-related framework, the mortality and case fatality rate was the highest scored factor (8.97), whereas within the vaccine-related framework, efficacy of the vaccine was considered the most important factor (9.56). On average, Spn, Hib, and HepA had the highest priority scores. Conclusion: The Korean experts suggested that the main factors influencing the decision to adopt new vaccines in the Korean NIP should be disease mortality, case fatality, and the efficacy and effectiveness of the vaccine. Among the five selected VPDs, Spn, Hib, and HepA were considered to be of higher priority than RV and HPV.",
keywords = "Delphi survey, National Immunization Program, Priority",
author = "Choe, {Young June} and Han, {Ok Pil} and Heeyeon Cho and Bae, {Geun Ryang} and Byung-Chul Chun and Kim, {Jong Hyun} and Kim, {Kyung Hyo} and Lee, {Hoan Jong} and Choi, {Eun Hwa}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.vaccine.2014.09.009",
language = "English",
volume = "32",
pages = "6049--6053",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "46",

}

TY - JOUR

T1 - Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea

AU - Choe, Young June

AU - Han, Ok Pil

AU - Cho, Heeyeon

AU - Bae, Geun Ryang

AU - Chun, Byung-Chul

AU - Kim, Jong Hyun

AU - Kim, Kyung Hyo

AU - Lee, Hoan Jong

AU - Choi, Eun Hwa

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background: This study was performed to determine the priority of vaccine introduction for five vaccine-preventable diseases (VPDs) caused by Haemophilus influenzae type b (Hib), pneumococcus (Spn), hepatitis A virus (HepA), rotavirus (RV), and human papillomavirus (HPV) to the future Korean National Immunization Program (NIP) and to suggest framework programs to assist decision makers on implementation of the NIP. Methods: Following analysis of the disease burden and economics of the five VPDs by the core team and Korean Advisory Committee on Immunization Practices sub-committee members, a Delphi survey was administered to 94 Korean experts using structured questionnaires that provided the reference data. The two evaluation frameworks for NIP prioritization were (1) a disease-related framework and (2) a vaccine-related framework. After analyzing the responses, a meeting of experts was held to build a consensus for determining how to prioritize NIP implementation. Results: The average scores for relative importance were 63.29 for the disease-related framework and 36.71 for the vaccine-related framework. Within the disease-related framework, the mortality and case fatality rate was the highest scored factor (8.97), whereas within the vaccine-related framework, efficacy of the vaccine was considered the most important factor (9.56). On average, Spn, Hib, and HepA had the highest priority scores. Conclusion: The Korean experts suggested that the main factors influencing the decision to adopt new vaccines in the Korean NIP should be disease mortality, case fatality, and the efficacy and effectiveness of the vaccine. Among the five selected VPDs, Spn, Hib, and HepA were considered to be of higher priority than RV and HPV.

AB - Background: This study was performed to determine the priority of vaccine introduction for five vaccine-preventable diseases (VPDs) caused by Haemophilus influenzae type b (Hib), pneumococcus (Spn), hepatitis A virus (HepA), rotavirus (RV), and human papillomavirus (HPV) to the future Korean National Immunization Program (NIP) and to suggest framework programs to assist decision makers on implementation of the NIP. Methods: Following analysis of the disease burden and economics of the five VPDs by the core team and Korean Advisory Committee on Immunization Practices sub-committee members, a Delphi survey was administered to 94 Korean experts using structured questionnaires that provided the reference data. The two evaluation frameworks for NIP prioritization were (1) a disease-related framework and (2) a vaccine-related framework. After analyzing the responses, a meeting of experts was held to build a consensus for determining how to prioritize NIP implementation. Results: The average scores for relative importance were 63.29 for the disease-related framework and 36.71 for the vaccine-related framework. Within the disease-related framework, the mortality and case fatality rate was the highest scored factor (8.97), whereas within the vaccine-related framework, efficacy of the vaccine was considered the most important factor (9.56). On average, Spn, Hib, and HepA had the highest priority scores. Conclusion: The Korean experts suggested that the main factors influencing the decision to adopt new vaccines in the Korean NIP should be disease mortality, case fatality, and the efficacy and effectiveness of the vaccine. Among the five selected VPDs, Spn, Hib, and HepA were considered to be of higher priority than RV and HPV.

KW - Delphi survey

KW - National Immunization Program

KW - Priority

UR - http://www.scopus.com/inward/record.url?scp=84907996748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907996748&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2014.09.009

DO - 10.1016/j.vaccine.2014.09.009

M3 - Article

C2 - 25239482

AN - SCOPUS:84907996748

VL - 32

SP - 6049

EP - 6053

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 46

ER -